Search Results - "D’Avolio, Antonio"
-
1
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease
Published in Journal of antimicrobial chemotherapy (01-07-2020)“…Abstract Background Remdesivir has received significant attention for its potential application in the treatment of COVID-19, caused by SARS-CoV-2. Remdesivir…”
Get full text
Journal Article -
2
LC-MS application for therapeutic drug monitoring in alternative matrices
Published in Journal of pharmaceutical and biomedical analysis (20-03-2019)“…•Last five years literature about LC–MS has been checked for this review.•Newest technologies and devices have been deeply described and discussed.•The most…”
Get full text
Journal Article -
3
Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients
Published in American journal of obstetrics and gynecology (01-04-2021)“…The disease caused by the severe acute respiratory syndrome coronavirus 2 was named coronavirus disease 2019 and classified as a global public health…”
Get full text
Journal Article -
4
Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism
Published in The journal of clinical endocrinology and metabolism (01-09-2021)“…Abstract Context Although current international guidelines recommend to avoid mineralocortcoid receptor antagonists in patients undergoing screening test for…”
Get full text
Journal Article -
5
Pharmacokinetics and pharmacogenetics of high-dosage tedizolid for disseminated nocardiosis in a lung transplant patient
Published in Journal of antimicrobial chemotherapy (01-12-2023)Get full text
Journal Article -
6
Efficacy and safety of a single switch from etanercept originator to etanercept biosimilar in a cohort of inflammatory arthritis
Published in Scientific reports (30-09-2020)“…AntiTNF-α biosimilars are broadly available for the treatment of inflammatory arthritis. There are a lot of data concerning the maintenance of clinical…”
Get full text
Journal Article -
7
Development and validation of UHPLC–MS/MS methods for the quantification of colistin in plasma and dried plasma spots
Published in Journal of pharmaceutical and biomedical analysis (10-09-2016)“…[Display omitted] •A new method to quantify colistin A and B in dried plasma spots (DPS) is reported.•The method was compared to a standard method to quantify…”
Get full text
Journal Article -
8
Comparative Performance Assessment of Novel Fluorescence Immunoassay POCTs for Measuring Circulating Levels of Vitamin-D
Published in Molecules (Basel, Switzerland) (01-04-2024)“…Vitamin D (Vit D) is a fat-soluble molecule acting like a hormone, and it is involved in several biological mechanisms such as gene expression, calcium…”
Get full text
Journal Article -
9
Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin
Published in Clinical infectious diseases (15-05-2024)“…Abstract Background Critical drug-drug interactions (DDI) and hepatotoxicity complicate concurrent use of rifampicin and protease inhibitors. We investigated…”
Get full text
Journal Article -
10
A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics?
Published in Current drug metabolism (01-01-2014)“…Drug bioavailability may vary greatly amongst individuals, affecting both efficacy and toxicity: in humans, genetic variations account for a relevant…”
Get more information
Journal Article -
11
A UHPLC–MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma
Published in Journal of pharmaceutical and biomedical analysis (05-06-2016)“…[Display omitted] •First UHPLC–MS/MS method to quantify all current anti-HCV direct acting antivirals.•Full validation according to FDA guidelines.•High…”
Get full text
Journal Article -
12
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV
Published in Clinical pharmacokinetics (2021)“…Background People living with human immunodeficiency virus are ageing under combination antiretroviral treatments but data on drug exposure in serum and…”
Get full text
Journal Article -
13
A simple high performance liquid chromatography–mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples
Published in Journal of pharmaceutical and biomedical analysis (25-10-2017)“…Overlaid chromatograms showing the retention times of Fluconazole (FLU), Voriconazole (VRC), Posaconazole (PSC), Isavuconazole (ISC), Itraconazole (ITC) and…”
Get full text
Journal Article -
14
Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots
Published in Clinical chemistry and laboratory medicine (01-02-2015)“…Therapeutic drug monitoring (TDM) of antiepileptic drugs is widely used in clinical practice to optimise therapy, but it is limited by technical problems and…”
Get more information
Journal Article -
15
The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study
Published in Antimicrobial agents and chemotherapy (21-06-2022)“…Ritonavir-boosted darunavir (DRV/r) and dolutegravir (DTG) are affected by induction of metabolizing enzymes and efflux transporters caused by rifampicin…”
Get full text
Journal Article -
16
Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy
Published in Pharmaceutics (01-09-2023)“…Background: Fosfomycin acts against aerobic Gram−/+ bacteria by blocking the synthesis of peptidoglycan. Its use has been currently re-evaluated for…”
Get full text
Journal Article -
17
An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR)
Published in Current controlled trials in cardiovascular medicine (23-11-2021)“…Remdesivir is a novel broad-spectrum antiviral therapeutic with activity against several viruses that cause emerging infectious diseases. The purpose of this…”
Get full text
Journal Article -
18
Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease
Published in Nutrients (29-12-2022)“…The coronavirus disease (COVID-19) pandemic represents a global health challenge, particularly considering concomitant diseases. Patients with inflammatory…”
Get full text
Journal Article -
19
LC-MS/MS-Based Quantification of 9 Antiepileptic Drugs From a Dried Sample Spot Device
Published in Therapeutic drug monitoring (01-06-2019)“…Therapeutic drug monitoring (TDM) of antiepileptic drugs (AEDs) is commonly performed on plasma or serum. The use of dried plasma spots (DPSs) could represent…”
Get full text
Journal Article -
20
Lack of concordance between EMIT assay and LC-MS/MS for Therapeutic Drug Monitoring of Mycophenolic Acid: Potential increased risk for graft rejection?
Published in Journal of pharmaceutical and biomedical analysis (05-08-2020)“…[Display omitted] •Analysis of concordance between EMIT and LC–MS/MS for TDM of Mycophenolic Acid.•Accuracy of LC–MS/MS method was tested by proficiency and…”
Get full text
Journal Article